Investor Presentation
GVB ACQUSITION COMPLETES 22ND CENTURY'S B2B CAPABILITIES
22nd Century now provides the most complete hemp/cannabis solution, from receptor science and
transformative plant genetics, to finished ingredients and CDMO formulated products that meet the
most exacting standards required by global consumer products and pharmaceutical companies.
Number of
Participants
Plant Profile
/ Roadmap
Canna Metrix
CannaMetrix's high-
throughput proprietary,
human cell-based assay
technology serves as a
roadmap for developing
new plant lines with
tailor-made profiles.
Few
Plant
Biotechnology
Ke Gene
Established proprietary
bioinformatics platform
and cutting-edge
molecular breeding
platform in partnership
with KeyGene; capabilities
include genetic
engineering and plant
line development.
Dozens
(Few are advanced)
Plant Breeding
& Trials
Extractas
Bioscience
Multiple partnerships with
top global breeders
provide 22nd Century
with both northern and
southern hemisphere,
indoor and outdoor, year-
round plant breeding and
trial capabilities.
Few
Ingredient Extraction,
Purification, and
Finished Products
GVB BIOPHARMA™
Hemp-derived active
ingredients extractor
and finished products
manufacturer providing
customers with bulk
ingredients and white
label products
Dozens
(Very few are reputable
and with scale)
Commercial
Partners
22ND CENTURY GROUP
22nd Century offers an
end-to-end, high-value
add solution for leading
nutraceutical, consumer
products and
pharmaceutical companies
entering the ascendant
cannabis market
Thousands
14View entire presentation